Paradigm Biocapital Advisors as of June 30, 2022
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 23 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Legend Biotech Corp Sponsored Ads (LEGN) | 10.7 | $54M | 979k | 55.00 | |
| Global Blood Therapeutics In | 9.2 | $46M | 1.4M | 31.95 | |
| Mirati Therapeutics | 8.8 | $44M | 660k | 67.13 | |
| Sierra Oncology Com New | 8.8 | $44M | 801k | 54.99 | |
| Incyte Corporation (INCY) | 8.4 | $42M | 556k | 75.97 | |
| Ascendis Pharma A/s Sponsored Adr (ASND) | 8.0 | $40M | 432k | 92.96 | |
| United Therapeutics Corporation (UTHR) | 7.7 | $38M | 163k | 235.64 | |
| Argenx Se Sponsored Adr (ARGX) | 6.7 | $34M | 89k | 378.88 | |
| Immunocore Hldgs Ads (IMCR) | 5.0 | $25M | 667k | 37.31 | |
| Arvinas Ord (ARVN) | 4.3 | $22M | 517k | 42.09 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.5 | $18M | 1.0M | 16.78 | |
| Syndax Pharmaceuticals (SNDX) | 3.4 | $17M | 876k | 19.24 | |
| Miragen Therapeutics (VRDN) | 3.0 | $15M | 1.3M | 11.57 | |
| Merus N V (MRUS) | 2.0 | $10M | 452k | 22.64 | |
| Esperion Therapeutics (ESPR) | 1.8 | $9.0M | 1.4M | 6.36 | |
| Tg Therapeutics (TGTX) | 1.7 | $8.4M | 2.0M | 4.25 | |
| Alpine Immune Sciences (ALPN) | 1.4 | $7.0M | 827k | 8.51 | |
| Enanta Pharmaceuticals (ENTA) | 1.4 | $7.0M | 148k | 47.27 | |
| Vor Biopharma (VOR) | 1.3 | $6.5M | 1.3M | 4.97 | |
| Oyster Point Pharma | 1.2 | $5.8M | 1.3M | 4.33 | |
| Gracell Biotechnologies Sponsored Ads | 0.9 | $4.3M | 783k | 5.50 | |
| Liquidia Corporation Com New (LQDA) | 0.7 | $3.7M | 851k | 4.36 | |
| C4 Therapeutics Com Stk (CCCC) | 0.1 | $552k | 73k | 7.55 |
